|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 487/14 | |
| A61K 31/4375 | |||
| A61P 25/00 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2688890 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12723932.5 |
| Europos patento paraiškos padavimo data | 2012-03-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-01-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-08-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IN2012/000191 |
| Data | 2012-03-21 |
| (87) | Numeris | WO 2012/127506 |
| Data | 2012-09-27 |
| (30) | Numeris | Data | Šalis |
| 891CH2011 | 2011-03-22 | IN |
| (72) |
BARAWKAR, Dinesh, IN
BENDE, Tanushree, IN
ZAHLER, Robert, US
BANDYOPADHYAY, Anish, IN
SARANGTHEM, Robindro Singh, IN
DOSHI, Jignesh, IN
WAMAN, Yogesh, IN
JADHAV, Rushikesh, IN
SINGH, Umesh Prasad, IN
|
| (73) |
Advinus Therapeutics Limited,
21 & 22, Peenya Industrial Area, Phase II, Bangalore 560058,
IN
|
| (54) | SUBSTITUTED FUSED TRICYCLIC COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF |
| SUBSTITUTED FUSED TRICYCLIC COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF |